First-Line Chemoradiation With or Without Chidamide (Tucidinostat) in Patients With Intermediate- and High-Risk Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma: A Randomized Phase 2 Study in China

作者：Yue Chai, Bo Chen, Fei Qi, Hui Fang, Shunan Qi, Ruyuan Guo, Ning Li, Yong Yang, Shulian Wang, Yongwen Song, Jianliang Yang, Di Zhang, Yuce Wei, Ye‐Xiong Li, Mei Dong · 发表于：International Journal of Radiation Oncology*Biology*Physics · 年份：2022 · DOI：10.1016/j.ijrobp.2022.04.001 · 被引用次数：15 · 研究领域：Lymphoma Diagnosis and Treatment、Head and Neck Cancer Studies、Immune Cell Function and Interaction